177 related articles for article (PubMed ID: 32409958)
21. LncRNA LINC00319 accelerates ovarian cancer progression through miR-423-5p/NACC1 pathway.
Du W; Feng Z; Sun Q
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):198-202. PubMed ID: 30442370
[TBL] [Abstract][Full Text] [Related]
22. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
[TBL] [Abstract][Full Text] [Related]
23. MiR-138-5p suppresses lung adenocarcinoma cell epithelial-mesenchymal transition, proliferation and metastasis by targeting ZEB2.
Zhu D; Gu L; Li Z; Jin W; Lu Q; Ren T
Pathol Res Pract; 2019 May; 215(5):861-872. PubMed ID: 30712885
[TBL] [Abstract][Full Text] [Related]
24. Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells.
Yoshimura A; Sawada K; Nakamura K; Kinose Y; Nakatsuka E; Kobayashi M; Miyamoto M; Ishida K; Matsumoto Y; Kodama M; Hashimoto K; Mabuchi S; Kimura T
BMC Cancer; 2018 Nov; 18(1):1065. PubMed ID: 30396333
[TBL] [Abstract][Full Text] [Related]
25. miR-129-5p attenuates cell proliferation and epithelial mesenchymal transition via HMGB1 in gastric cancer.
Wang S; Chen Y; Yu X; Lu Y; Wang H; Wu F; Teng L
Pathol Res Pract; 2019 Apr; 215(4):676-682. PubMed ID: 30635217
[TBL] [Abstract][Full Text] [Related]
26. MiR-425-5p accelerated the proliferation, migration, and invasion of ovarian cancer cells via targeting AFF4.
Wu Z; Guo J; Zhang Y; Liu J; Ma H; Tang Y
J Ovarian Res; 2021 Oct; 14(1):138. PubMed ID: 34686190
[TBL] [Abstract][Full Text] [Related]
27. Down-regulation of microRNA-31-5p inhibits proliferation and invasion of osteosarcoma cells through Wnt/β-catenin signaling pathway by enhancing AXIN1.
Chen X; Zhong L; Li X; Liu W; Zhao Y; Li J
Exp Mol Pathol; 2019 Jun; 108():32-41. PubMed ID: 30844369
[TBL] [Abstract][Full Text] [Related]
28. Exosomal miR-21-5p contributes to ovarian cancer progression by regulating CDK6.
Cao J; Zhang Y; Mu J; Yang D; Gu X; Zhang J
Hum Cell; 2021 Jul; 34(4):1185-1196. PubMed ID: 33813728
[TBL] [Abstract][Full Text] [Related]
29. LAMC2 regulated by microRNA-125a-5p accelerates the progression of ovarian cancer via activating p38 MAPK signalling.
Zhang D; Guo H; Feng W; Qiu H
Life Sci; 2019 Sep; 232():116648. PubMed ID: 31301414
[TBL] [Abstract][Full Text] [Related]
30. Targeting miR-21-3p inhibits proliferation and invasion of ovarian cancer cells.
Báez-Vega PM; Echevarría Vargas IM; Valiyeva F; Encarnación-Rosado J; Roman A; Flores J; Marcos-Martínez MJ; Vivas-Mejía PE
Oncotarget; 2016 Jun; 7(24):36321-36337. PubMed ID: 27166999
[TBL] [Abstract][Full Text] [Related]
31. miR-382 inhibits migration and invasion by targeting ROR1 through regulating EMT in ovarian cancer.
Tan H; He Q; Gong G; Wang Y; Li J; Wang J; Zhu D; Wu X
Int J Oncol; 2016 Jan; 48(1):181-90. PubMed ID: 26575700
[TBL] [Abstract][Full Text] [Related]
32. CUL4A functions as an oncogene in ovarian cancer and is directly regulated by miR-494.
Han X; Fang Z; Wang H; Jiao R; Zhou J; Fang N
Biochem Biophys Res Commun; 2016 Nov; 480(4):675-681. PubMed ID: 27983981
[TBL] [Abstract][Full Text] [Related]
33. Non-coding RNA LOXL1-AS1 exhibits oncogenic activity in ovarian cancer via regulation of miR-18b-5p/VMA21 axis.
Xue F; Xu YH; Shen CC; Qin ZL; Zhou HB
Biomed Pharmacother; 2020 May; 125():109568. PubMed ID: 32058209
[TBL] [Abstract][Full Text] [Related]
34. MiR-206 inhibits epithelial ovarian cancer cells growth and invasion via blocking c-Met/AKT/mTOR signaling pathway.
Dai C; Xie Y; Zhuang X; Yuan Z
Biomed Pharmacother; 2018 Aug; 104():763-770. PubMed ID: 29807226
[TBL] [Abstract][Full Text] [Related]
35. Ginsenoside 20(S)-Rg3 Prevents PKM2-Targeting miR-324-5p from H19 Sponging to Antagonize the Warburg Effect in Ovarian Cancer Cells.
Zheng X; Zhou Y; Chen W; Chen L; Lu J; He F; Li X; Zhao L
Cell Physiol Biochem; 2018; 51(3):1340-1353. PubMed ID: 30481782
[TBL] [Abstract][Full Text] [Related]
36. MiR-373 targeting of the Rab22a oncogene suppresses tumor invasion and metastasis in ovarian cancer.
Zhang Y; Zhao FJ; Chen LL; Wang LQ; Nephew KP; Wu YL; Zhang S
Oncotarget; 2014 Dec; 5(23):12291-303. PubMed ID: 25460499
[TBL] [Abstract][Full Text] [Related]
37. miR-485-5p inhibits the progression of breast cancer cells by negatively regulating MUC1.
Wang X; Zhou X; Zeng F; Wu X; Li H
Breast Cancer; 2020 Jul; 27(4):765-775. PubMed ID: 32144736
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-153 functions as a tumor suppressor by targeting SET7 and ZEB2 in ovarian cancer cells.
Zhou J; Xie M; Shi Y; Luo B; Gong G; Li J; Wang J; Zhao W; Zi Y; Wu X; Wen J
Oncol Rep; 2015 Jul; 34(1):111-20. PubMed ID: 25954928
[TBL] [Abstract][Full Text] [Related]
39. miR-361-5p inhibits glioma migration and invasion by targeting SND1.
Liu J; Yang J; Yu L; Rao C; Wang Q; Sun C; Shi C; Hua D; Zhou X; Luo W; Wang R; Li W; Yu S
Onco Targets Ther; 2018; 11():5239-5252. PubMed ID: 30214229
[TBL] [Abstract][Full Text] [Related]
40. S100A7 Regulates Ovarian Cancer Cell Metastasis and Chemoresistance Through MAPK Signaling and Is Targeted by miR-330-5p.
Lin M; Xia B; Qin L; Chen H; Lou G
DNA Cell Biol; 2018 May; 37(5):491-500. PubMed ID: 29485916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
